Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Photo Avaluation

Sanofi

Status and phase

Completed

Phase 3

Conditions

Hygiene

Treatments

Drug: Dermacyd PH_DETINBACK (Lactic Acid)

Study type

Interventional

Funder types

Industry

Identifiers

NCT00785720

LACAC_L_04303

Details and patient eligibility

About

The purpose of this study is to demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDETINBACK Sweet Flower.

Enrollment

26 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Phototype Skin II and III;
Integral skin test in the region;
Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion criteria

Lactation or gestation
Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection;
Diseases which can cause immunity decrease, such as HIV, diabetes;
Use of drug photosensitizer;
History of sensitivity or irritation for topic products;
Active cutaneous disease which can change the study results;
History of photodermatosis active;
Family or personal antecedent of cutaneous photoinduced neoplasias;
Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and queratoses actinium;
Intense solar exposure in the study area;
Use of new drugs or cosmetics during the study